Results Snapshot
Quarterly Analysis Highlights - QoQ
Net Sales
QoQ Growth in quarter ended Sep 2025 is 9.09% vs -59.38% in Jun 2025
Standalone Net Profit
QoQ Growth in quarter ended Sep 2025 is 131.07% vs -80.89% in Jun 2025
Operating Profit (PBDIT) excl Other Income
QoQ Growth in quarter ended Sep 2025 is -131.82% vs -81.97% in Jun 2025
Interest
QoQ Growth in quarter ended Sep 2025 is 7.41% vs 0.00% in Jun 2025
Operating Profit Margin (Excl OI)
QoQ Growth in quarter ended Sep 2025 has fallen from Jun 2025
Compare Quarterly Results Of Shukra Pharma. With
Quarterly - Net Sales
QoQ Growth in quarter ended Sep 2025 is 9.09% vs -59.38% in Jun 2025
YoY Growth in quarter ended Sep 2025 is 5.76% vs -77.44% in Sep 2024
Quarterly - Standalone Net Profit
QoQ Growth in quarter ended Sep 2025 is 131.07% vs -80.89% in Jun 2025
YoY Growth in quarter ended Sep 2025 is 340.74% vs -88.54% in Sep 2024
Quarterly - Operating Profit (PBDIT)
QoQ Growth in quarter ended Sep 2025 is -131.82% vs -81.97% in Jun 2025
YoY Growth in quarter ended Sep 2025 is -162.69% vs -86.84% in Sep 2024
Quarterly - Interest
QoQ Growth in quarter ended Sep 2025 is 7.41% vs 0.00% in Jun 2025
YoY Growth in quarter ended Sep 2025 is 163.64% vs 83.33% in Sep 2024
Quarterly - Operating Profit Margin (Excl OI)
QoQ Growth in quarter ended Sep 2025 has fallen from Jun 2025
YoY Growth in quarter ended Sep 2025 has fallen from Sep 2024






